ArticleCancer research2026

Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Mandana Kamgar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.